A deep learning-based system for survival benefit prediction of tyrosine kinase inhibitors and immune checkpoint inhibitors in stage IV non-small cell lung cancer patients: A multicenter, prognostic study

Autor: Deng, Kexue, Wang, Lu, Liu, Yuchan, Li, Xin, Hou, Qiuyang, Cao, Mulan, Ng, Nathan Norton, Wang, Huan, Chen, Huanhuan, Yeom, Kristen W., Zhao, Mingfang, Wu, Ning, Gao, Peng, Shi, Jingyun, Liu, Zaiyi, Li, Weimin, Tian, Jie, Song, Jiangdian
Zdroj: In eClinicalMedicine September 2022 51
Databáze: ScienceDirect